Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | B-lymphocyte antigen CD19 binding agent | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | D054198 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594618 |
CONTENTS